Media

Oncopeptides issues warrants to utilize the first loan tranche from EIB

Fusion Pharmaceuticals Announces Opening Of Radiopharmaceutical Manufacturing Facility To Produce Targeted Alpha Therapies For Cancer

Pulmonx Reports First Quarter 2023 Financial Results

Invitation to presentation of the Q1 Report 2023

BONESUPPORT Holding AB (PUBL) – Punlishes Q1 2023 interim report

Oncopeptides publishes the 2022 annual report

Oncopeptides presents new scientific data at European Myeloma Network Meeting

Fusion Pharmaceuticals Announces Presentation Of Preclinical Data Supporting FPI-2059 And Leading Targeted Alpha Therapy Platform At AACR Annual Meeting

Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline

Carisma Therapeutics to Present at The American Association for Cancer Research Annual Meeting